Related references
Note: Only part of the references are listed.High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy
Nicolas Hunzelmann et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension
Karen C. Patterson et al.
ANNALS OF INTERNAL MEDICINE (2006)
Increased expression of integrin αvβ3 contributes to the establishment of autocrine TGF-β signaling in scleroderma fibroblasts
Y Asano et al.
JOURNAL OF IMMUNOLOGY (2005)
Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-β signaling in cultured scleroderma fibroblasts
Y Mimura et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Increased expression levels of integrin αvβ5 on scleroderma fibroblasts
Y Asano et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice
XK Zhang et al.
JOURNAL OF IMMUNOLOGY (2004)
Phosphatidylinositol 3-kinase is involved in α2(I) collagen gene expression in normal and scleroderma fibroblasts
Y Asano et al.
JOURNAL OF IMMUNOLOGY (2004)
Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin
M Kubo et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Quantitative genetic variation in CD19 expression correlates with autoimmunity
S Sato et al.
JOURNAL OF IMMUNOLOGY (2000)
Long-term outcomes of scleroderma renal crisis
VD Steen et al.
ANNALS OF INTERNAL MEDICINE (2000)
A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis
P Teder et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)
Share Paper
